Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul C Engel

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
Human Mutation|August 10, 2005
Marked decrease in specific activity contributes to disease phenotype in two human glucose 6-phosphate dehydrogenase mutants, G6PD(Union) and G6PD(Andalus)Xiao-Tao Wang, Veronica M S Lam, Paul C Engel
Journal of Biotechnology|September 26, 2006
Phenylalanine dehydrogenase mutants: efficient biocatalysts for synthesis of non-natural phenylalanine derivativesFrancesca Paradisi, Stuart Collins, Anita R Maguire, et al.
FEBS Letters|May 10, 2005
Identification of the residue responsible for catalysing regeneration of activity in the inactive glutamate dehydrogenase mutant D165NFrancesca Paradisi, Ruth Woolfson, Kieran F Geoghegan, et al.
Biochimica Et Biophysica Acta|August 29, 2006
Functional properties of two mutants of human glucose 6-phosphate dehydrogenase, R393G and R393H, corresponding to the clinical variants G6PD Wisconsin and NashvilleXiao-Tao Wang, Veronica M S Lam, Paul C Engel
Biochimica Et Biophysica Acta|July 28, 2011
Molecular recruitment as a basis for negative dominant inheritance? propagation of misfolding in oligomers of IMPDH1, the mutated enzyme in the RP10 form of retinitis pigmentosaXiao-Tao Wang, Brian Mion, Aileen Aherne, et al.
The FEBS Journal|July 4, 2012
Reversal of the extreme coenzyme selectivity of Clostridium symbiosum glutamate dehydrogenaseMichael A Sharkey, Alessandro Gori, Marina Capone, et al.
Molecular and Biochemical Parasitology|April 20, 2010
Susceptibility of Plasmodium falciparum to glutamate dehydrogenase inhibitors--a possible new antimalarial targetIsabela M Aparicio, Alejandro Marín-Menéndez, Angus Bell, et al.
Archives of Microbiology|May 14, 2011
Kinetic characterisation of recombinant Corynebacterium glutamicum NAD+-dependent LDH over-expressed in E. coli and its rescue of an lldD- phenotype in C. glutamicum: the issue of reversibility re-examinedMichael A Sharkey, Marcus A Maher, Armel Guyonvarch, et al.
Acta Crystallographica. Section F, Structural Biology Communications|June 16, 2016
Crystal structure of a chimaeric bacterial glutamate dehydrogenaseTânia Oliveira, Michael A Sharkey, Paul C Engel, et al.
Organic & Biomolecular Chemistry|December 17, 2008
Engineered dehydrogenase biocatalysts for non-natural amino acids: efficient isolation of the D-enantiomer from racemic mixturesFrancesca Paradisi, Philip A Conway, Anita R Maguire, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
Human Mutation|August 10, 2005
Marked decrease in specific activity contributes to disease phenotype in two human glucose 6-phosphate dehydrogenase mutants, G6PD(Union) and G6PD(Andalus)Xiao-Tao Wang, Veronica M S Lam, Paul C Engel
Journal of Biotechnology|September 26, 2006
Phenylalanine dehydrogenase mutants: efficient biocatalysts for synthesis of non-natural phenylalanine derivativesFrancesca Paradisi, Stuart Collins, Anita R Maguire, et al.
FEBS Letters|May 10, 2005
Identification of the residue responsible for catalysing regeneration of activity in the inactive glutamate dehydrogenase mutant D165NFrancesca Paradisi, Ruth Woolfson, Kieran F Geoghegan, et al.
Biochimica Et Biophysica Acta|August 29, 2006
Functional properties of two mutants of human glucose 6-phosphate dehydrogenase, R393G and R393H, corresponding to the clinical variants G6PD Wisconsin and NashvilleXiao-Tao Wang, Veronica M S Lam, Paul C Engel
Biochimica Et Biophysica Acta|July 28, 2011
Molecular recruitment as a basis for negative dominant inheritance? propagation of misfolding in oligomers of IMPDH1, the mutated enzyme in the RP10 form of retinitis pigmentosaXiao-Tao Wang, Brian Mion, Aileen Aherne, et al.
The FEBS Journal|July 4, 2012
Reversal of the extreme coenzyme selectivity of Clostridium symbiosum glutamate dehydrogenaseMichael A Sharkey, Alessandro Gori, Marina Capone, et al.
Molecular and Biochemical Parasitology|April 20, 2010
Susceptibility of Plasmodium falciparum to glutamate dehydrogenase inhibitors--a possible new antimalarial targetIsabela M Aparicio, Alejandro Marín-Menéndez, Angus Bell, et al.
Archives of Microbiology|May 14, 2011
Kinetic characterisation of recombinant Corynebacterium glutamicum NAD+-dependent LDH over-expressed in E. coli and its rescue of an lldD- phenotype in C. glutamicum: the issue of reversibility re-examinedMichael A Sharkey, Marcus A Maher, Armel Guyonvarch, et al.
Acta Crystallographica. Section F, Structural Biology Communications|June 16, 2016
Crystal structure of a chimaeric bacterial glutamate dehydrogenaseTânia Oliveira, Michael A Sharkey, Paul C Engel, et al.
Organic & Biomolecular Chemistry|December 17, 2008
Engineered dehydrogenase biocatalysts for non-natural amino acids: efficient isolation of the D-enantiomer from racemic mixturesFrancesca Paradisi, Philip A Conway, Anita R Maguire, et al.
Pageof 5